Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pancreatic cancer. Management.

M Hidalgo Pascual1, E Ferrero Herrero, P Peláez Torres

  • 1Universidad Complutense, Hospital Universitario 12 de Octubre, Madrid, Spain. mhidalgo.hdoc@salud.madrid.org

Revista Espanola De Enfermedades Digestivas
|December 9, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medial incisional ventral hernia repair with Adhesix<sup>®</sup> autoadhesive mesh: descriptive study.

Hernia : the journal of hernias and abdominal wall surgery·2023
Same author

First wave of COVID-19 impact on emergency general surgery in a Spanish tertiary hospital. A cohort study.

Acta chirurgica Belgica·2021
Same author

Classification of primary and incisional abdominal wall hernias.

Hernia : the journal of hernias and abdominal wall surgery·2009
Same author

Starting a new program of split liver transplantation after a low learning curve: a reality in centers with large experience in liver surgery and whole liver transplantation.

Hepato-gastroenterology·2008
Same author

Transhiatal esophagectomy for squamous cell carcinoma in liver transplant recipients.

Hepato-gastroenterology·2008
Same author

[Effect of endothelin-1 on tumor arteries in patients with colorectal cancer].

Revista espanola de enfermedades digestivas·2008
Same journal

Very late entecavir resistance after more than 10 years of therapy in a treatment-naïve patient with chronic hepatitis B genotype D3.

Revista espanola de enfermedades digestivas·2026
Same journal

Beyond the scalpel ‒ The critical impact of lifestyle and tumor biology in non-cirrhotic hepatocellular carcinoma.

Revista espanola de enfermedades digestivas·2026
Same journal

Automated extraction of colonoscopy quality indicators from free-text reports using a prompt-based large language model pipeline.

Revista espanola de enfermedades digestivas·2026
Same journal

Ultra-processed food intake and risk of inflammatory bowel disease in the adult population ‒ A systematic review and meta-analysis.

Revista espanola de enfermedades digestivas·2026
Same journal

Persistent geographic inequalities in oesophageal cancer mortality in Spain despite overall declines.

Revista espanola de enfermedades digestivas·2026
Same journal

Diagnostic and therapeutic considerations in m.3243A>G-associated chronic intestinal pseudo-obstruction.

Revista espanola de enfermedades digestivas·2026
See all related articles

Pancreatic cancer remains a significant health challenge with limited treatment options. While surgery offers the only curative approach, it has modest long-term survival rates and associated risks, even at expert centers.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gastroenterology

Background:

  • Pancreatic cancer presents a major unmet medical need.
  • Current treatments are insufficient to address the disease burden.

Purpose of the Study:

  • To review the current state of pancreatic cancer treatment.
  • To highlight the limitations of existing therapeutic strategies.

Main Methods:

  • Literature review of pancreatic cancer treatment outcomes.
  • Analysis of surgical survival rates, mortality, and morbidity data.

Main Results:

  • Surgery is the sole potentially curative option for pancreatic cancer.
  • Three-year survival rates following surgery are approximately 30-35%.

Related Experiment Videos

  • Operative mortality is below 3%, with morbidity around 10% in expert centers.

    • Conclusions:

    • Despite advancements, pancreatic cancer remains difficult to treat effectively.
    • Surgical outcomes, while improved in specialized centers, still indicate a need for better therapeutic options.